PROPANC BIOPHARMA, INC. Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
PROPANC BIOPHARMA, INC. (PPCB) reported Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount of -$995.55 thousand for the 12-month period ending 2020-06-30, per its 10-K filed 2020-10-01.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate · last filed 2020-10-01
- PROPANC BIOPHARMA, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2020 was -$995.55K.
- PROPANC BIOPHARMA, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2019 was -$1.21M.
- PROPANC BIOPHARMA, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2018 was -$1.48M.
- PROPANC BIOPHARMA, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2017 was -$1.83M.
| Period end | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month as first filed |
|---|---|---|
| 2020-06-30 | -$995.55K 10-K · filed 2020-10-01 | |
| 2019-06-30 | -$1.21M 10-K · filed 2020-10-01 | |
| 2018-06-30 | -$1.48M 10-K · filed 2019-10-15 | -$2.33M 10-K · filed 2018-09-17 |
| 2017-06-30 | -$1.83M 10-K · filed 2018-09-17 | |
| 2016-06-30 | -$2.19M 10-K · filed 2017-09-28 | |
| 2015-06-30 | -$672.09K 10-K · filed 2016-09-28 | |
| 2014-06-30 | -$274.23K 10-K · filed 2015-09-30 | |
| 2013-06-30 | -$492.33K 10-K · filed 2014-10-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |